IP Verse

Methods For Modulating Chemotherapeutic Cytotoxicity - EP2968536

The patent EP2968536 was granted to The United States OF America on Jun 28, 2023. The application was originally filed on Mar 13, 2014 under application number EP14718255A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2968536

THE UNITED STATES OF AMERICA
Application Number
EP14718255A
Filing Date
Mar 13, 2014
Status
Granted And Under Opposition
May 26, 2023
Publication Date
Jun 28, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

JAMES POOLEMar 27, 2024CARPMAELS & RANSFORDADMISSIBLE

Patent Citations (50) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS4235871
DESCRIPTIONUS4501728
DESCRIPTIONUS4837028
DESCRIPTIONUS4902505
DESCRIPTIONUS4957735
DESCRIPTIONUS4987071
DESCRIPTIONUS5004697
DESCRIPTIONUS5019369
DESCRIPTIONUS5055303
DESCRIPTIONUS5188837
DESCRIPTIONUS5254342
DESCRIPTIONUS5268164
DESCRIPTIONUS5271961
DESCRIPTIONUS5357041
DESCRIPTIONUS5399667
DESCRIPTIONUS5413797
DESCRIPTIONUS5491130
DESCRIPTIONUS5506206
DESCRIPTIONUS5514670
DESCRIPTIONUS5534496
DESCRIPTIONUS5543508
DESCRIPTIONUS5627265
DESCRIPTIONUS5700486
DESCRIPTIONUS5728396
DESCRIPTIONUS5770563
DESCRIPTIONUS5849701
DESCRIPTIONUS5939380
DESCRIPTIONUS5993414
DESCRIPTIONUS6051549
DESCRIPTIONUS6384189
DESCRIPTIONUS6436091
DESCRIPTIONUS6458767
DESCRIPTIONUS6469138
DESCRIPTIONUS7129052
DESCRIPTIONUS8236313
DESCRIPTIONWO2008060785
DESCRIPTIONWO2010017332
DESCRIPTIONWO9522618
EXAMINATIONWO2011143624
EXAMINATIONWO2012170250
INTERNATIONAL-SEARCH-REPORTUS2006188508
INTERNATIONAL-SEARCH-REPORTUS2009191202
INTERNATIONAL-SEARCH-REPORTWO2008060785
INTERNATIONAL-SEARCH-REPORTWO2010017332
INTERNATIONAL-SEARCH-REPORTWO2011034969
INTERNATIONAL-SEARCH-REPORTWO2011076781
INTERNATIONAL-SEARCH-REPORTWO2014012479
OPPOSITIONUS2014296477
OPPOSITIONWO2004096133
OPPOSITIONWO2013007933

Non-Patent Literature (NPL) Citations (5) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
EXAMINATION- MAXHIMER JUSTIN B ET AL, "Thrombospondin-1/CD47 blockade following ischemia-reperfusion injury is tissue protective.", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, (200912), Database accession no. NLM19952644
EXAMINATION- MAXHIMER JUSTIN B ET AL, "Thrombospondin-1/CD47 blockade following ischemia-reperfusion injury is tissue protective.", PLASTIC AND RECONSTRUCTIVE SURGERY DEC 2009, (200912), vol. 124, no. 6, ISSN 1529-4242, pages 1880 - 1889
EXAMINATION- CHAO MARK P ET AL, "Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma", CELL, CELL PRESS, (20100901), vol. 142, no. 5, doi:10.1016/J.CELL.2010.07.044, ISSN 0092-8674, pages 699 - 713, XP009160294
OPPOSITION- Anonymous, "Doxorbicin 2MG/ML concentrate for solution for infusion (doxorubicin hydrochloride) 50 MG in 25 ML / Doxorbicin 2MG/25 ML concentrate for solution for infusion (doxorubicin hydrochloride) 10 MG / 5 ML", Safeguarding public health, (20060101), pages 1 - 40
OPPOSITION- E Sick, A Jeanne, C Schneider, S Dedieu, K Takeda, L Martiny, "CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest", British journal of pharmacology, UK , (20121201), vol. 167, no. 7, doi:10.1111/j.1476-5381.2012.02099.x, ISSN 0007-1188, pages 1415 - 1430, XP055247122

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents